Unusual Features of Gastrointestinal Stromal Tumor on PET/CT and CT Imaging

被引:25
|
作者
Wong, Chun-Sing [1 ]
Chu, Yiu-Ching Tiffany [2 ]
Khong, Pek-Lan [1 ]
机构
[1] Univ Hong Kong, Li Ka Shing Fac Med, Dept Diagnost Radiol, Hong Kong, Hong Kong, Peoples R China
[2] Kwong Wah Hosp, Dept Radiol, Hong Kong, Hong Kong, Peoples R China
关键词
gastrointestinal stromal tumor; imatinib; lymphatic metastasis; prostatic neoplasm; pancreatic neoplasm; intestinal obstruction; rupture; RESPONSE EVALUATION; INTERSTITIAL-CELLS; IMATINIB MESYLATE; GIST; MANAGEMENT; PROSTATE; PROGNOSIS; DIAGNOSIS; PATHOLOGY; THERAPY;
D O I
10.1097/RLU.0b013e31820aa233
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Gastrointestinal stromal tumor (GIST) is the most common mesenchymal tumor of the gastrointestinal tract. It can be benign or malignant in behavior. Stomach, being the most common site (70%) for GISTs, is followed by the small intestine (20%). Anorectal, colonic, and esophageal GISTs are uncommon, whereas extraintestinal GISTs are extremely rare. The presenting symptoms are highly dependent on tumor size and location, although a large number of GISTs are asymptomatic. The purpose of this article is to highlight the unusual characteristics of GISTs illustrated by PET/CT and CT imaging. These characteristics are organized into (1) unusual tumor location, (2) unusual clinical presentation, and (3) unusual sites of metastasis. Knowing the uncommon features of GISTs is important, as they are more often seen nowadays with the increasingly important role of PET/CT and CT in GIST management; and these tumors are associated with a poorer prognosis and unwanted delay in diagnosis is avoidable. With the availability of effective treatment by imatinib mesylate, a prompt and early diagnosis is essential for disease control. All GISTs illustrated in this article are pathologically proven.
引用
收藏
页码:E1 / E7
页数:7
相关论文
共 50 条
  • [21] Primary Extragastrointestinal Stromal Tumor on FDG PET/CT
    Zhang, Yanyan
    Zhang, Annan
    Song, Le
    Li, Xinxin
    Zhang, Weifang
    CLINICAL NUCLEAR MEDICINE, 2018, 43 (09) : 702 - 703
  • [22] Role of DOTANOC PET/CT in the Management of Gastrointestinal Stromal Tumors
    Sagar, S.
    Khan, D.
    Kundu, S. K. V. N.
    Viswanathan, R.
    Roy, A.
    Nayak, B.
    Kumar, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S511 - S511
  • [23] CT and PET: Early prognostic indicators of response to imatinib mesylate in patients with gastrointestinal stromal tumor
    Holdsworth, Clay H.
    Badawi, Ramsey D.
    Manola, Judith B.
    Kijewski, Marie F.
    Israel, David A.
    Demetri, George D.
    Van den Abbeele, Annick D.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2007, 189 (06) : W324 - W330
  • [24] Monitoring the Effect of Targeted Therapies in a Gastrointestinal Stromal Tumor Xenograft Using a Clinical PET/CT
    Revheim, Mona-Elisabeth
    Roe, Kathrine
    Bruland, Oyvind Sverre
    Bach-Gansmo, Tore
    Skretting, Arne
    Seierstad, Therese
    MOLECULAR IMAGING AND BIOLOGY, 2011, 13 (06) : 1234 - 1240
  • [25] Concomitant Lung Cancer and Gastrointestinal Stromal Tumor First Report of Hypoxia Imaging With 18F-FAZA PET/CT
    Mapelli, Paola
    Incerti, Elena
    Fallanca, Federico
    Bettinardi, Valentino
    Compierchio, Antonia
    Masiello, Valeria
    Doglioni, Claudio
    Rossetti, Francesca
    Negri, Giampiero
    Gianolli, Luigi
    Picchio, Maria
    CLINICAL NUCLEAR MEDICINE, 2017, 42 (07) : E349 - E351
  • [26] 18F-FDG PET/CT and contrast enhanced CT in differential diagnosis between leiomyoma and gastrointestinal stromal tumor
    Hirose, Yasumitus
    Kaida, Hayato
    Kawahara, Akihiko
    Kurata, Seiji
    Ishibashi, Masatoshi
    Abe, Toshi
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2015, 18 (03): : 257 - 260
  • [27] Inflammatory Myofibroblastic Tumor Mimicking Gastric Gastrointestinal Stromal Tumor on 18F-FDG PET/CT
    Chong, Ari
    Ha, Jung-Min
    Hong, Ran
    Park, Sang-Gon
    Lee, Hee Jeong
    CLINICAL NUCLEAR MEDICINE, 2014, 39 (08) : 725 - 727
  • [28] 68Ga-FAPI-04 PET/CT Versus 18F-FDG PET/CT in the Detection of Malignant Gastrointestinal Stromal Tumor
    Zhang, Zeyu
    Jiang, Hongyuan
    Zhang, Lu
    Cheng, Chao
    Zuo, Changjing
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (01) : 61 - 63
  • [29] Comparison of PET, CT, and dual-modality PET/CT imaging for monitoring of imatinib (STI571) therapy in patients with gastrointestinal stromal tumors
    Antoch, G
    Kanja, J
    Bauer, S
    Kuehl, H
    Renzing-Koehler, K
    Schuette, J
    Bockisch, A
    Debatin, JF
    Freudenberg, LS
    JOURNAL OF NUCLEAR MEDICINE, 2004, 45 (03) : 357 - 365
  • [30] Association between CT imaging features and KIT mutations in small intestinal gastrointestinal stromal tumors
    Yi-qiong Yin
    Chun-juan Liu
    Bo Zhang
    Yue Wen
    Yuan Yin
    Scientific Reports, 9